CDMRP PRMRP Focused Program Award | W81XWH 21 PRMRP FPA

Opportunity Information: Apply for W81XWH 21 PRMRP FPA

The CDMRP Peer Reviewed Medical Research Program (PRMRP) Focused Program Award is a Department of Defense funding opportunity designed to push a research area forward faster by organizing a coordinated, team-based program around one clear, high-impact problem. Instead of funding a single standalone study, this mechanism supports a synergistic set of projects that collectively aim to answer a critical question or solve a major challenge tied to at least one of the Congressionally directed FY21 PRMRP Topic Areas. The intent is optimization and acceleration: building an integrated program where multiple disciplines and perspectives converge to produce a stronger translational payoff than any one project could deliver on its own.

A central requirement is the definition of a unifying, overarching challenge. Applicants must articulate a single, coherent challenge that anchors the entire program and is directly relevant to an important research and/or patient care need within an FY21 PRMRP Topic Area. This overarching challenge is essentially the organizing thesis of the application: it should be specific enough to guide decision-making and milestone setting, but significant enough that solving it would meaningfully advance the field or improve clinical outcomes.

The program must be constructed from multiple distinct research projects led by individual project leaders. The solicitation strongly encourages submitting at least four projects, with additional studies allowed. Each project should address a different but complementary facet of the overarching challenge, and the projects should be intentionally interrelated so that their results inform and strengthen one another. At the same time, the award is not meant to fund a fragile chain of dependencies where the whole program collapses if one project fails. The expectation is that every project can stand on its own scientific merit and produce publishable, impactful results, while still contributing to a larger integrated solution. The opportunity explicitly welcomes exploring multiple hypotheses or viewpoints around the same central line of questioning, which underscores the emphasis on thoughtful program design rather than a single narrow experimental path.

In terms of scope, the individual projects can range from early exploratory and hypothesis-building work through small-scale clinical trials, up to and including Phase 2 (or equivalent). Even if some projects start at an earlier stage, the program should show a clear intent to progress toward translational and clinical applicability over the course of the award. In other words, the research can span discovery to early clinical testing, but the overall direction should be moving toward real-world use rather than stopping at purely basic findings.

A major part of the application is the implementation plan. Applicants are expected to provide a detailed plan that maps how the team will execute the program, including critical milestones, the resources and technical innovations that will be used, and how success will be measured over time. Where appropriate, the program should include robust statistical planning and access to statistical expertise. The implementation plan must also explain how the team will assess performance at two levels: the health and progress of each individual project, and the collective progress toward solving the overarching challenge. For multi-institutional teams, the application must address practical coordination issues such as communication routines, data transfer workflows, and how shared data, specimens, and/or products will be managed. The program also requires an intellectual and material property plan agreed to by participating organizations and included in the supporting documentation, reflecting the expectation that collaborative outputs will be handled in a clear, pre-negotiated way.

The opportunity encourages the use of an External Advisory Board (EAB) to strengthen guidance and accountability, but it also warns applicants to avoid conflicts of interest during peer review. The key constraint is that applicants should not contact, recruit, or name specific EAB members in the application itself, which is meant to preserve integrity and independence in the review process while still allowing a thoughtful advisory structure after award.

Leadership and team composition are treated as essential to the award’s purpose. The overall program must be led by a Principal Investigator with demonstrated experience running large, focused efforts, and the PI must commit at least 20 percent effort to the award. The PI is expected to actively build a collaborative environment that promotes innovation and meaningful integration across projects, not just oversee a collection of loosely connected activities. Each project must have a designated project leader, and the overall team should be multidisciplinary, with the combined expertise and resources forming a cohesive, synergistic partnership.

From an administrative perspective, this opportunity was issued by the Department of Defense, Department of the Army, USAMRAA under Funding Opportunity Number W81XWH-21-PRMRP-FPA. It falls under CFDA 12.420 and supports science, technology, and other research and development activities. The listing indicates the funding instrument could be a grant or a cooperative agreement, which typically implies that some awards may involve more active involvement from the funding agency. Consistent with that, the PRMRP Science Officer assigned to an award should be invited to participate in team meetings, such as annual full-team meetings, and the application should describe the plan for those meetings. Eligibility is described as unrestricted (open to any entity type), subject to any clarifications provided in the full announcement. The opportunity was created March 15, 2021, with an original closing date of August 26, 2021, and anticipated making around five awards; the award ceiling is listed as 0 in the source data, which usually signals that applicants must rely on the full solicitation for the actual budget limits or that limits were expressed elsewhere.

Overall, the PRMRP Focused Program Award is best understood as a mechanism for well-managed, milestone-driven, multi-project programs that can move a targeted medical research area toward practical solutions, including translational outputs and early-stage clinical evaluation, by deliberately combining complementary projects under a single strategic vision.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "CDMRP PRMRP Focused Program Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Mar 15, 2021.
• Applicants must submit their applications by Aug 26, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 5 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 PRMRP FPA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: